Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Unlocking Your HSA's Potential for Retirement | David Seufer, CFA of Gravitas Wealth Planning
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
David Seufer is the CFA of Gravitas Wealth Planning
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Exploring Colt CZ's New Firearms: VP Paul Spitale Unveils Innovations Amid Merger Talks
00:10:00
Powering Independence: The Rise of Off-Grid and Decentralized Energy in the Nordics | Lars Eriksson - Energy Systems Specialist, Nordic Energy Research
00:10:00
Abijit Bora's Analysis of the Union Budget Highlights Fiscal Prudence and Sector Impacts
00:10:00
Prashant Kumar on Yes Bank's Transformation and Future Prospects | Prashant Kumar, CEO , Yes Bank Ltd.
00:10:00
Building a High-Performance Culture: Key Ingredients and Leadership Strategies
00:10:00
Meet Trailhead Planners: Your Partner in Financial Success | Morgan Ranstrom - Partner & Lead Financial Planner , Financial Map Maker of Trailhead Planners, LLC
00:10:00
extensive industry insider networks to help businesses|Cristina Nunez, General Partner,True Beauty Ventures
00:10:00
Understanding Arbitrage Funds: Navigating Market Opportunities and Risks | Expert Insights on Investment Strategies
00:10:00
Exploring Cameroon: Oriole Resources' Gold Exploration Efforts
00:10:00
HALO Trust and MMD Demining Sizer: Clearing Zimbabwe's Mines for a Safer Future | Chad Cretney - VP of MMD Mineral Sizing (Canada) Inc.
00:10:00
DEUTZ CMD 2023: CEO Sebastian Schulte's Strategy Update | Dr. Sebastian C. Schulte - CEO of DEUTZ AG
00:10:00
leading home healthcare technology platform that aims to radically transform|Julia Andre,Partner,Index Ventures